The Levonorgestrel Intrauterine System: Reasons to Expand Access to the Public Sector of Africa
Hubacher, D.
Global Health Science and Practice 3(4): 532-537
2015
ISSN/ISBN: 2169-575X PMID: 26681701 DOI: 10.9745/ghsp-d-15-00178Document Number: 641949
Document emailed within 0-6 h
Related Documents
Dahab, M.; Kielmann, K.; Charalambous, S.; Karstaedt, A.S.; Hamilton, R.; La Grange, L.; Fielding, K.L.; Churchyard, G.J.; Grant, A.D. 2011: Contrasting reasons for discontinuation of antiretroviral therapy in workplace and public-sector HIV programs in South Africa Aids Patient Care and Stds 25(1): 53-59Jacobs, N.; Schneider, H.; Van Rensburg, H.C.J. 2008: Rationing access to public-sector antiretroviral treatment during scale-up in South Africa: implications for equity African Journal of Aids Research: Ajar 7(1): 19-27
Steyn, F.; Schneider, H.; Engelbrecht, M.C.; van Rensburg-Bonthuyzen, E.Janse.; Jacobs, N.; van Rensburg, D.H.C.J. 2009: Scaling up access to antiretroviral drugs in a middle-income country: public sector drug delivery in the Free State, South Africa Aids Care 21(1): 1-6
Beattie, M.C.; Hu, T.-W.; Li, R.; Bond, J.C. 2005: Cost-effectiveness of public sector substance abuse treatment: comparison of a managed care approach to a traditional public sector system Journal of Behavioral Health Services and Research 32(4): 409-429
Munteanu, O.; Cirstoiu, M.; Antoniac, I.; Cirstoiu, C. 2016: Comparison of Pain Level During and After Intrauterine Device Insertion: Levonorgestrel-Releasing Intrauterine System Versus the Copper T Intrauterine Device Environmental Engineering and Management Journal 15(5): 965-972
Apen, K.; Kapoor, S. 2011: Viable intrauterine pregnancy with levonorgestrel intrauterine system in situ--a case report Australian and New Zealand Journal of Obstetrics and Gynaecology 51(4): 381-382
Bilgehan, F.; Dilbaz, B.; Karadag, B.; Deveci, C.D. 2015: Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception Journal of Obstetrics and Gynaecology Research 41(9): 1426-1432
Bosco-Lévy, P.; Gouverneur, A.; Langlade, C.; Miremont, G.; Pariente, A. 2019: Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study Contraception 99(6): 345-349
Toivonen, J.; Luukkainen, T.; Allonen, H. 1991: Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices Obstetrics and Gynecology 77(2): 261-264
Toivonen, J.; Luukkainen, T.; Allonen, H. 1991: Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices Obstetrics and Gynecology 77(2): 261-264
Katurura, M.C.; Cilliers, L. 2018: Electronic health record system in the public health care sector of South Africa: A systematic literature review African Journal of Primary Health Care and Family Medicine 10(1): E1-E8
Godfrey, E.M.; Memmel, L.M.; Neustadt, A.; Shah, M.; Nicosia, A.; Moorthie, M.; Gilliam, M. 2010: Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T 380A Contraception 81(2): 123-127
Ng, Y.W.; Liang, S.; Singh, K. 2009: Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative study Contraception 79(1): 24-28
Wouters, E.; Meulemans, H.; van Rensburg, H.C.J. 2009: Slow to share: social capital and its role in public HIV disclosure among public sector ART patients in the Free State province of South Africa Aids Care 21(4): 411-421
Mitchell, M.; Hedt, B.L.; Eshun-Wilson, I.; Fraser, H.; John, M-Anne.; Menezes, C.; Grobusch, M.P.; Jackson, J.; Taljaard, J.; Lesh, N. 2012: Electronic decision protocols for ART patient triaging to expand access to HIV treatment in South Africa: a cross sectional study for development and validation International Journal of Medical Informatics 81(3): 166-172
Imperato, F.; Perniola, G.; Mossa, B.; Marziani, R.; Perniola, F.; Stragapede, B.; Napolitano, C. 2002: The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years) Minerva Ginecologica 54(3): 271-278
Melvin, L.; Scott, J.; Craik, J. 2014: Jaydess® levonorgestrel intrauterine system Journal of Family Planning and Reproductive Health Care 40(3): 165-169
Shaamash, A.H.; Sayed, G.H.; Hussien, M.M.; Shaaban, M.M. 2005: A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development Contraception 72(5): 346-351
Shaamash, A.H.; Sayed, G.H.; Hussien, M.M.; Shaaban, M.M. 2005: A comparative study of the levonorgestrel-releasing intrauterine system Mirena® versus the Copper T380A intrauterine device during lactation : breast-feeding performance, infant growth and infant development Contraception (Stoneham) 72(5): 346-351
Foster, D.G.; Biggs, M.A.; Phillips, K.A.; Grindlay, K.; Grossman, D. 2015: Potential public sector cost-savings from over-the-counter access to oral contraceptives Contraception 91(5): 373-379